-
mmk68 replied to the topic "PM Problem Involving Pre-clinical Trial Results and Market Entry Deadlines" – 3 months ago
If the stents fail during in-vivo testing, the team as an entirety would need to re-assess the design. It would be critical to understand why the stents are failing and possible avenues to rectify that. It is also possible that… Read more»